Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Large-scale testing (Phase 3)Looking for participantsNCT07082114
What this trial is testing

Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 800
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07221214
What this trial is testing

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Who this might be right for
HIVAlcoholSmoking Cigarette+1 more
Vanderbilt University Medical Center 200
Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Not applicableStudy completedNCT06236672
What this trial is testing

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Type 2 DiabetesChronic Kidney Diseases
LMC Diabetes & Endocrinology Ltd. 348
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Early research (Phase 1)Looking for participantsNCT05071898
What this trial is testing

Pharmacogenetics of Response to GLP1R Agonists

Who this might be right for
ObesityDiabetes Type 2
University of Maryland, Baltimore 600
Early research (Phase 1)Study completedNCT03341013
What this trial is testing

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 24
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07021937
What this trial is testing

Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

Who this might be right for
Obesity/Therapy
University of Colorado, Denver 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07251556
What this trial is testing

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Who this might be right for
Psoriasis Arthritis
Chinese University of Hong Kong 40
Not applicableNot Yet RecruitingNCT07213323
What this trial is testing

Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

Who this might be right for
Obesity &Amp; OverweightDigestive Disorders
Hospices Civils de Lyon 50
Not applicableUnknownNCT03959865
What this trial is testing

GLP-1 REceptor Agonists and Real World EvIdeNce

Who this might be right for
Type 2 Diabetes
University of Padova 6,000
Large-scale testing (Phase 3)Enrolling By InvitationNCT06162715
What this trial is testing

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Who this might be right for
Severe ObesityObesityBMI Greater Than 30
Vanderbilt University Medical Center 30
Post-approval studies (Phase 4)Study completedNCT01744236
What this trial is testing

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 70
Not applicableNot Yet RecruitingNCT06775093
What this trial is testing

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

Who this might be right for
Polycystic Ovary SyndromeObesityInfertility, Female
Peking University Third Hospital 392
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06500299
What this trial is testing

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Who this might be right for
Overweight and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 180
Not applicableNot Yet RecruitingNCT06388213
What this trial is testing

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Who this might be right for
Diabetes Mellitus, Type 2AnesthesiaPulmonary Aspiration of Gastric Contents
University Hospital, Geneva 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019197
What this trial is testing

Effects of Semaglutide in HIV-Associated Lipohypertrophy

Who this might be right for
HIV/AIDSLipohypertrophyObesity
Case Western Reserve University 108
Post-approval studies (Phase 4)Looking for participantsNCT06324461
What this trial is testing

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

Who this might be right for
Myocardial Injury
The University of Hong Kong 372
Load More Results